- Home
- FWRD vs LIMN Comparison
FWRD vs LIMN Comparison
Compare FWRD & LIMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FWRD
- LIMN
- Stock Information
- Founded
- FWRD 1981
- LIMN 2018
- Country
- FWRD United States
- LIMN United States
- Employees
- FWRD N/A
- LIMN N/A
- Industry
- FWRD Oil Refining/Marketing
- LIMN
- Sector
- FWRD Consumer Discretionary
- LIMN
- Exchange
- FWRD Nasdaq
- LIMN NYSE
- Market Cap
- FWRD 674.8M
- LIMN 623.8M
- IPO Year
- FWRD 1993
- LIMN N/A
- Fundamental
- Price
- FWRD $26.50
- LIMN $9.11
- Analyst Decision
- FWRD Buy
- LIMN
- Analyst Count
- FWRD 4
- LIMN 0
- Target Price
- FWRD $29.67
- LIMN N/A
- AVG Volume (30 Days)
- FWRD 649.8K
- LIMN 663.1K
- Earning Date
- FWRD 08-06-2025
- LIMN 01-01-0001
- Dividend Yield
- FWRD N/A
- LIMN N/A
- EPS Growth
- FWRD N/A
- LIMN N/A
- EPS
- FWRD N/A
- LIMN N/A
- Revenue
- FWRD $2,545,730,000.00
- LIMN N/A
- Revenue This Year
- FWRD $5.57
- LIMN N/A
- Revenue Next Year
- FWRD $7.43
- LIMN N/A
- P/E Ratio
- FWRD N/A
- LIMN N/A
- Revenue Growth
- FWRD 63.73
- LIMN N/A
- 52 Week Low
- FWRD $9.79
- LIMN $4.40
- 52 Week High
- FWRD $40.92
- LIMN $33.66
- Technical
- Relative Strength Index (RSI)
- FWRD 76.86
- LIMN N/A
- Support Level
- FWRD $23.88
- LIMN N/A
- Resistance Level
- FWRD $25.76
- LIMN N/A
- Average True Range (ATR)
- FWRD 1.29
- LIMN 0.00
- MACD
- FWRD 0.36
- LIMN 0.00
- Stochastic Oscillator
- FWRD 97.10
- LIMN 0.00
About FWRD Forward Air Corporation
Forward Air Corp is an asset-light freight and logistics company. The company's operating segment includes Expedited Freight, Omni Logistics, and Intermodal and Corporate. The company generates maximum revenue from the Omni Logistics segment. The expedited Freight segment operates a comprehensive national network to provide expedited regional, inter-regional, and national LTL (less-than-truckload) services. It also offers customers local pick-up and delivery and other services including final mile, truckload, shipment consolidation and deconsolidation, warehousing, customs brokerage, and other handling. The Company conducts business in the United States, Canada, and Mexico.
About LIMN LIMINATUS PHARMA INC
Liminatus Pharma Inc is a clinical-stage biopharmaceutical company. The company is engaged in developing cancer therapies and treatments. The GCC Vaccine of the company is in Phase II of clinical trials designed for immune behavior towards colorectal, pancreatic, gastric, and esophageal cancers that express Guanylyl Cyclase C.